-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HLVaKvygTDVWKzCl3vWlOUZqhjc7srT7BGf786cnL57fGKrgXqQFhXrf8Dcp1uIQ ZD8xjABs5KQ8cHs4g9bZtQ== 0001209191-10-017780.txt : 20100318 0001209191-10-017780.hdr.sgml : 20100318 20100318143652 ACCESSION NUMBER: 0001209191-10-017780 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100316 FILED AS OF DATE: 20100318 DATE AS OF CHANGE: 20100318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHAPPELL JOHN F CENTRAL INDEX KEY: 0001053880 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23265 FILM NUMBER: 10691265 MAIL ADDRESS: STREET 1: 8540 COLONNADE CENTER DRIVE STREET 2: SUITE 501 CITY: RALEIGH STATE: NC ZIP: 27615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SALIX PHARMACEUTICALS LTD CENTRAL INDEX KEY: 0001009356 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943267443 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1700 PERIMETER PARK DRIVE CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: (919) 862-1000 MAIL ADDRESS: STREET 1: 1700 PERIMETER PARK DRIVE CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: SALIX HOLDINGS LTD DATE OF NAME CHANGE: 19970807 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2010-03-16 0 0001009356 SALIX PHARMACEUTICALS LTD SLXP 0001053880 CHAPPELL JOHN F 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560 1 0 0 0 Common Stock 2010-03-16 4 S 0 25000 30.4972 D 519120 D Common Stock 250000 I By GRAT Option to Buy Common Stock 17.63 2015-06-09 Common Stock 15000 15000 D Option to Buy Common Stock 18.8733 2014-06-17 Common Stock 22500 22500 D Option to Buy Common Stock 7.60 2013-07-24 Common Stock 15000 15000 D Option to Buy Common Stock 4.0666 2012-07-02 Common Stock 15000 15000 D Option to Buy Common Stock 4.92 2001-01-01 2010-12-31 Common Stock 22500 22500 D The shares were sold pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.32 to $30.69, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. These shares were previously reported as directly benefically owned but were contributed to a grantor retained annuity trust on October 30, 2007. Options are 100% vested. /s/ John F. Chappell 2010-03-18 -----END PRIVACY-ENHANCED MESSAGE-----